Activation of MYC pathway is a unifying pathological event in the progression from monoclonal gammopathy of undetermined significance (MGUS) to myeloma (MM)

被引：0
|
作者：
Chng, Wee J. [1 ]
Chesi, Marta [1 ]
Price-Troska, Tammy [2 ]
Ahmann, Greg [1 ]
Henderson, Kim [2 ]
Greipp, Philip [2 ]
Kyle, Robert [2 ]
Rajkumar, S. Vincent [2 ]
Gertz, Morie [2 ]
Fonseca, Rafael [1 ]
Bergsagel, P. Leif [1 ]
机构：
[1] Mayo Clin, Scottsdale, AZ USA
[2] Mayo Clin, Dept Hematol, Rochester, MN USA
来源：
BLOOD | 2007年 / 110卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
241
引用
收藏
页码：78A / 78A
页数：1
相关论文
共 50 条
  • [21] Hormone Replacement Therapy and Risk of Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance (MGUS) and MGUS Progression in the UK Clinical Practice Research Datalink
    Bradley, Marie C.
    McShane, Charlene
    Hughes, Carmel M.
    Landgren, Ola
    Murray, Liam
    Anderson, Lesley A.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 : 176 - 176
  • [22] Immune Cells, Cytokines, and Gut Microbiota Landscape Along Monoclonal Gammopathy of Undetermined Significance (MGUS) to Multiple Myeloma (MM) Evolution
    Corsale, Anna Maria
    Di Simone, Marta
    Azgomi, Mojtaba Shekarkar
    Speciale, Maria
    Gigliotta, Emilia
    Garofano, Francesca
    Aquilina, Cristina
    Vullo, Candida
    Caccamo, Nadia
    Dieli, Francesco
    Meraviglia, Serena
    Siragusa, Sergio
    Botta, Cirino
    BLOOD, 2023, 142
  • [23] Cytogenetic Features Of Patients With Monoclonal Gammopathy Of Undetermined Significance (MGUS) and Asymptomatic Multiple Myeloma (AMM)
    Tian, Erming
    Waheed, Sarah
    Sawyer, Jeffrey
    Zhang, Qing
    Heuck, Christoph
    Dhodapkar, Madhav V.
    Barlogie, Bart
    Epstein, Joshua
    BLOOD, 2013, 122 (21)
  • [24] Multiple myeloma disguised as monoclonal gammopathy of undetermined significance? MGUS-like phenotype of a multiple myeloma subgroup
    Hammami, Emna
    HEMATOLOGIE, 2023, 29 (04): : 218 - 219
  • [25] Evaluation of Genes and Molecular Pathways Involved in the Progression of Monoclonal Gammopathy of Undetermined Significance (MGUS) to Multiple Myeloma: A Systems Biology Approach
    Parisa Khalili
    Reza Maddah
    Mohsen Maleknia
    Bahareh Shateri Amiri
    Fatemeh Forouzani
    Afshin Hasanvand
    Hadi Rezaeeyan
    Molecular Biotechnology, 2023, 65 : 1275 - 1286
  • [26] Evaluation of Genes and Molecular Pathways Involved in the Progression of Monoclonal Gammopathy of Undetermined Significance (MGUS) to Multiple Myeloma: A Systems Biology Approach
    Khalili, Parisa
    Maddah, Reza
    Maleknia, Mohsen
    Amiri, Bahareh Shateri
    Forouzani, Fatemeh
    Hasanvand, Afshin
    Rezaeeyan, Hadi
    MOLECULAR BIOTECHNOLOGY, 2023, 65 (08) : 1275 - 1286
  • [27] Progression of Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma in a Solid Organ Transplant
    Redfield, Robert R.
    Naji, Ali
    TRANSPLANTATION, 2011, 92 (12) : E65 - E66
  • [28] Association of Progression Patterns in Monoclonal Gammopathy of Undetermined Significance (MGUS) with Outcome in Multiple Myeloma: A Cohort Study of over 35 Years
    Spath, Florentin
    Tahiru, Widad
    Izarra, Antonio
    Hultdin, Johan
    Wu, Wendy Yi-Ying
    BLOOD, 2021, 138 : 3790 - +
  • [29] Molecular and biologic markers of progression in monoclonal gammopathy of undetermined significance to multiple myeloma
    Mailankody, Sham
    Mena, Esther
    Yuan, Constance M.
    Balakumaran, Arun
    Kuehl, W. Michael
    Landgren, Ola
    LEUKEMIA & LYMPHOMA, 2010, 51 (12) : 2159 - 2170
  • [30] Risk of Progression in Monoclonal Gammopathy of Undetermined Significance (MGUS): Results from a Population-Based Screening Study
    Lindqvist, Ebba K.
    Lund, Sigrun H.
    Costello, Rene
    Burton, Debra
    Korde, Neha S.
    Mailankody, Sham
    Bjorkholm, Magnus
    Eiriksdottir, Gudny
    Launer, Leonore J.
    Harris, Tamara B.
    Hultcrantz, Malin
    Gudnason, Vilmundur
    Landgren, Ola
    Kristinsson, Sigurdur Y.
    BLOOD, 2016, 128 (22)
12345